[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343111-105":59,"doc-detail-343111-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrating-single-cell-rna-seq-to-identify-fibroblast-based-molecular-subtypes-for-predicting-prognosis-and-therapeutic-response-in-bladder-cancer-research-paper","Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer - Research Paper","","Bladder cancer is an aggressive, heterogeneous malignancy where immunotherapy offers promise but only benefits a subset of patients. Fibroblasts, key stromal components of the tumor microenvironment, are implicated in progression and treatment resistance, yet their precise roles in bladder cancer remain unclear. Using single-cell RNA sequencing, fibroblast-defined molecular subtypes are generated and linked to overall survival and immunotherapy responsiveness through prognostic gene signatures and molecular and experimental validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-single-cell-rna-seq-to-identify-fibroblast-based-molecular-subtypes-for-predicting-prognosis-and-therapeutic-response-in-bladder-cancer-research-paper/343111/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-single-cell-rna-seq-to-identify-fibroblast-based-molecular-subtypes-for-predicting-prognosis-and-therapeutic-response-in-bladder-cancer-research-paper/343111.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are fibroblasts important for bladder cancer prognosis and immunotherapy response?","Question",{"text":112,"@type":113},"Fibroblasts are major stromal cells in the tumor microenvironment and can transform into cancer-associated fibroblasts that remodel the extracellular matrix and secrete immunosuppressive cytokines. These processes can promote immune evasion and affect treatment outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were fibroblast-based molecular subtypes identified in the study?",{"text":117,"@type":113},"Single-cell RNA-seq data for bladder cancer were processed using the Seurat workflow and visualized with UMAP. Marker genes were identified for each cluster using a marker-finding function, and fibroblast markers supported defining three molecular subtypes.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the ten-gene prognostic signature do?",{"text":121,"@type":113},"The study builds a ten-gene fibroblast marker-based signature to stratify patients into high- and low-risk groups. The signature was validated in internal and external validation sets and was associated with overall survival and immunotherapy response.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343111,1790727616,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 14  \nResearch Paper  \nIntegrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer  \nJia Wang1,2, Zhiyong Tan3, Yinglong Huang3, Charles Li4,5,6, Peiqin Zhan1,3, Haifeng Wang1,3, Haihao Li 1,3  \n1The Second Clinical Medical College, Kunming Medical University, Kunming, China  \n2 Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China 3 Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China 4Core Facility for Protein Research, Chinese Academy of Sciences, Beijing, China  \n5Zhongke Jianlan Medical Research Institute, Beijing, China  \n6Zhejiang Institute of Integrated Traditional and Western Medicine, Hangzhou, China  \nCorrespondence to: Haifeng Wang, Haihao Li; [email:](email: wanghaifeng@kmmu.edu.cn)[ ](email: wanghaifeng@kmmu.edu.cn)[wanghaifeng@kmmu.edu.cn](email: wanghaifeng@kmmu.edu.cn), [lihaihao@kmmu.edu.cn](lihaihao@kmmu.edu.cn)[ ](lihaihao@kmmu.edu.cn)[Keywords:](Keywords: scRNA-seq)[ scRNA-seq](Keywords: scRNA-seq), bladder cancer, prognostic signature, fibroblast cell, immunotherapy response  \nReceived: January 9, 2024 Accepted: July 5, 2024 Published: July 18, 2024  \nCopyright: © 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nBackground: Bladder cancer (BLCA) is a highly aggressive and heterogeneous disease, posing challenges for diagnosis and treatment. Cancer immunotherapy has recently emerged as a promising option for patients with advanced and drug-resistant cancers. Fibroblasts, a significant component of the tumor microenvironment, playa crucial role in tumor progression, but their precise function in BLCA remains uncertain.  \nMethods: Single-cell RNA sequencing (scRNA-seq) data for BLCA were obtained from the Gene Expression Omnibus database. The R package “Seurat” was used for processing scRNA-seq data, with uniform manifold approximation and projection (UMAP) for downscaling and cluster identification. The FindAllMarkers function identified marker genes for each cluster. Differentially expressed genes influencing overall survival (OS) of BLCA patients were identified using the limma package. Differences in clinicopathological characteristics, immune microenvironment, immune checkpoints, and chemotherapeutic drug sensitivity between high- and low-risk groups were investigated. RT-qPCR and immunohistochemistry validated the expression of prognostic genes.  \nResults: Fibroblast marker genes identified three molecular subtypes in the testing set. A prognostic signature comprising ten genes stratified BLCA patients into high-and low-score groups. This signature was validated in one internal and two external validation sets. High-score patients exhibited increased immune cell infiltration, elevated chemokine expression, and enhanced immune checkpoint expression but had poorer OS and a reduced response to immunotherapy. Six sensitive anti-tumor drugs were identified for the high-score group. RT-qPCR and immunohistochemistry showed that CERCAM, TM4SF1, FN1, ANXA1, and LOX were highly expressed, while EMP1, HEYL, FBN1, and SLC2A3 were downregulated in BLCA.  \nConclusion: A novel fibroblast marker gene-based signature was established, providing robust predictions of survival and immunotherapeutic response in BLCA patients.  \n11385  \nINTRODUCTION  \nBladder cancer (BLCA) is the 10th most common cancer worldwide, with uroepithelial carcinoma accounting for about 90% of cases. In 2020, there were approximately 573,000 new cases and 213,000 deaths globally [1, 2] . Despite various treatments, the prognosis for BLCA patients remains poor, with a median overa","cbCaigniyp2JxwCi","https://ap.wps.com/l/cbCaigniyp2JxwCi","pdf",5722719,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Burden and current treatments in bladder cancer\n## Limits of existing biomarkers for immunotherapy response\n## Role of tumor microenvironment and fibroblasts","[{\"question\":\"Why are fibroblasts important for bladder cancer prognosis and immunotherapy response?\",\"answer\":\"Fibroblasts are major stromal cells in the tumor microenvironment and can transform into cancer-associated fibroblasts that remodel the extracellular matrix and secrete immunosuppressive cytokines. These processes can promote immune evasion and affect treatment outcomes.\"},{\"question\":\"How were fibroblast-based molecular subtypes identified in the study?\",\"answer\":\"Single-cell RNA-seq data for bladder cancer were processed using the Seurat workflow and visualized with UMAP. Marker genes were identified for each cluster using a marker-finding function, and fibroblast markers supported defining three molecular subtypes.\"},{\"question\":\"What does the ten-gene prognostic signature do?\",\"answer\":\"The study builds a ten-gene fibroblast marker-based signature to stratify patients into high- and low-risk groups. The signature was validated in internal and external validation sets and was associated with overall survival and immunotherapy response.\"}]","Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer - Research Paper | PDF",1790049938,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22a501d10a20db22a56d16d25a5f4346.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9103043b8fb10faa38300bd0b6a9a883.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d73746082375b8b1ab419dfe79b3d679.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b362d2798852145a159cffb4c94226e.webp",980,1268]